Detalles de la búsqueda
1.
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745381
2.
Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
Antimicrob Agents Chemother
; 62(11)2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30104278
3.
Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model.
Antimicrob Agents Chemother
; 62(4)2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437610
4.
Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa.
J Antimicrob Chemother
; 71(11): 3157-3167, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27521357
5.
Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa.
J Antimicrob Chemother
; 70(3): 818-26, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25381167
6.
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant Klebsiella pneumoniae.
Comput Struct Biotechnol J
; 20: 1077-1087, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35284046
7.
Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling.
Pharmaceutics
; 11(9)2019 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31547301
Resultados
1 -
7
de 7
1
Próxima >
>>